Page results
-
This page explains what you can expect during recovery from your CAR T-cell therapy.
-
Professor Pandya is a consultant in fetal medicine at UCLH
-
Information about Magnetic Resonance Imaging (MRI) scans at UCLH.
-
Our nationally-recognised service helps children and young people (up to 19 years) with type 1 diabetes, type 2 diabetes, monogenic diabetes such as maturity onset diabetes in the young (MODY) and steroid related diabetes.
-
This information is about penile cancer multidisciplinary team (MDT), the a team of professionals who will be caring for you at University College Hospital (UCLH).
-
A safeguarding clinic dedicated to the long term needs of children and young people who have problems related to Sexual, gynaecological or genito-urinary health, Complex maltreatment including sexual abuse, female genital mutilation, factitious illness and related issues. We also see unaccompanied children, refugees and looked after children.
-
For patients aged 13-18 we have a dedicated team covering a range of conditions, particularly specialising in reconstructive urology.
-
The tissue viability team is committed to providing support, training and education to clinical staff, patients and carers about maintaining, promoting skin integrity and preventing pressure sores.
-
Our non-emergency patient transport service is provided by G4S. G4S may use approved external sub-contractors to meet the demand of the service and/or the specific needs of our patients.
-
This page provides information for employers, teachers, special needs education coordinators (SENCo) and other professionals who work alongside someone with Galactosaemia.
File results
-
FOI/2023/0237 - Software solution to manage patient e-consent for school vaccinations/ immunisations and waitlist validation
-
FOI/2023/0244 - IT systems for digital dictation, speech recognition, outsourced transcription, video consultation and health information systems
-
FOI/2023/0247 - Treatment guidelines for Idiopathic Pulmonary Fibrosis
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0249 - Treatments for clotting disorders - Haemophilia B, Von Willebrand Disease
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2023/0360 - Minutes of Board of Director meetings and Declarations of Interests (DoI) statements 2008-2023